LumiraDx Limited, headquartered in Great Britain, is a pioneering company in the point-of-care diagnostics industry. Founded in 2014, LumiraDx has rapidly established itself as a leader in developing innovative diagnostic solutions that enhance patient care and streamline clinical workflows. The company focuses on delivering advanced testing platforms and a range of diagnostic tests, including those for infectious diseases and chronic conditions. LumiraDx's unique microfluidic technology enables rapid, accurate results, setting it apart in a competitive market. With a strong presence in Europe and North America, LumiraDx has achieved significant milestones, including regulatory approvals and partnerships that bolster its market position. The company continues to drive advancements in healthcare diagnostics, making a meaningful impact on patient outcomes worldwide.
How does LumiraDx Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
LumiraDx Limited's score of 28 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
LumiraDx Limited, headquartered in Great Britain, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, LumiraDx has not inherited any emissions data from a parent company, nor does it have any commitments to initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). This lack of data and commitments suggests that LumiraDx may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is increasingly important for companies to establish clear carbon reduction targets and transparency in emissions reporting to align with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LumiraDx Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

